| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/24/2013 | US20130023485 Parenteral formulations of peptides for the treatment of systematic lupus erythematosus |
| 01/24/2013 | US20130023483 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 01/24/2013 | US20130023482 Crystalline form of cyclosporine a, methods of preparation, and methods for use thereof |
| 01/24/2013 | US20130023024 Conjugate of magnetic particle and surface modifier linked through cleavable peptide bond |
| 01/24/2013 | CA2842345A1 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| 01/24/2013 | CA2842268A1 Biomarkers for ankylosing spondylitis |
| 01/23/2013 | EP2548888A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 01/23/2013 | EP2548883A2 Peptide compounds that can be used as antibacterial agents |
| 01/23/2013 | EP2548882A1 Method for producing multiple recombinant disulfide bridged peptides |
| 01/23/2013 | EP2548017A2 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/23/2013 | EP2547700A1 Peptides or antibodies which bind to melanoma inhibitory activity (mia) protein |
| 01/23/2013 | EP2547693A2 Integrin interaction inhibitors for the treatment of cancer |
| 01/23/2013 | EP2547692A2 Peptide derivatives, preparation thereof and uses thereof as vectors |
| 01/23/2013 | EP2547691A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers |
| 01/23/2013 | EP2547690A2 Affinity peptides toward bmp-2 |
| 01/23/2013 | EP2261375B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 01/23/2013 | CN102892885A Iga-binding peptide and iga purification using same |
| 01/23/2013 | CN102892777A Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers |
| 01/23/2013 | CN102892776A Novel peptide and use thereof |
| 01/23/2013 | CN102887952A Monoclonal antibody against pbp2a derived from mrsa with dual binding activities |
| 01/23/2013 | CN102887943A B cell epitope peptide segment of amino-terminal pro-brain natriuretic peptide and applications thereof |
| 01/23/2013 | CN102887942A Ovarian-cancer-targeted polypeptide |
| 01/23/2013 | CN102887941A PAK (polyester alkyd)/ imidazoline/RGD (arginine-glycine-aspartic acid) ternary conjugate and preparation method and use thereof |
| 01/23/2013 | CN102167731B Method for preparing omiganan through solid phase peptide synthesis |
| 01/23/2013 | CN102120758B Mycobacterium tuberculosis antibody binding peptide and application thereof |
| 01/23/2013 | CN101991867B Multi-mode targeted probe for early hepatic fibrosis diagnosis and preparation method thereof |
| 01/23/2013 | CN101987866B Staphylococcus aureus Efb protein C-end antigen epitope, as well as preparation method and usage thereof |
| 01/22/2013 | US8357774 Polypeptide and process for producing the same |
| 01/22/2013 | US8357662 Surface-based ammonium ion sensor and methods of making thereof |
| 01/22/2013 | US8357654 Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs |
| 01/22/2013 | US8357494 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits |
| 01/22/2013 | CA2455638C Peptide-based multimeric targeted contrast agents |
| 01/22/2013 | CA2441970C Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/22/2013 | CA2346122C Stabilized bioactive peptides and methods of identification, synthesis and use |
| 01/17/2013 | WO2013010028A2 COMPOSITIONS AND METHODS FOR IMPROVED CaMKII INHIBITORS AND USES THEREOF |
| 01/17/2013 | WO2013009690A2 Leukemia stem cell targeting ligands and methods of use |
| 01/17/2013 | WO2013009165A1 A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine |
| 01/17/2013 | WO2013007643A1 In vitro assessment of cardiovascular events by assay for neo-epitopes of titin protein |
| 01/17/2013 | WO2013006978A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
| 01/17/2013 | WO2012161497A3 Peptide derivatives having a superior moisturizing effect and uses thereof |
| 01/17/2013 | WO2012119072A3 Compositions and methods for treatment of intracellular damage |
| 01/17/2013 | US20130018171 Purification of caspofungin intermediates |
| 01/17/2013 | US20130018004 Novel Protein Peptide Hydrogels |
| 01/17/2013 | US20130017600 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 01/17/2013 | US20130017253 Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions |
| 01/17/2013 | US20130017213 Peptide analogues |
| 01/17/2013 | CA2878701A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
| 01/17/2013 | CA2841516A1 Novel zinc finger-like peptide compositions as potent agents in cancer prevention and treatment |
| 01/16/2013 | EP2546342A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 01/16/2013 | EP2545171A1 Hjurp peptides and vaccines including the same |
| 01/16/2013 | CN1954073B Modified Bouganin proteins, cytotoxins and methods and uses thereof |
| 01/16/2013 | CN1838954B Glycogen synthase kinase-3 inhibitors |
| 01/16/2013 | CN102884190A HJURP peptides and vaccines including the same |
| 01/16/2013 | CN102884073A Peptides for promoting angiogenesis and a use thereof |
| 01/16/2013 | CN102883737A Method of treatment of type 2 diabetes |
| 01/16/2013 | CN102883734A Biosynthetic proline/alanine random coil polypeptides and their uses |
| 01/16/2013 | CN102875675A Anti-human serum albumin single-chain antibody and method for connecting polypeptide medicine with nitrogen terminal of antibody |
| 01/16/2013 | CN102875657A Method for preparing telomerase polypeptide vaccine |
| 01/16/2013 | CN102875656A Immunoglobuline E (IgE) specific binding polypeptide and medical application thereof |
| 01/16/2013 | CN102875655A Linaclotide synthesis method |
| 01/16/2013 | CN102875654A Method for preparing conotoxin polypeptide Eb1.6 |
| 01/16/2013 | CN102875653A Alpha-conotoxin peptide, and medical composition, preparation method and purpose thereof |
| 01/16/2013 | CN102875652A Method for separating and purifying daptomycin |
| 01/16/2013 | CN102875651A Anti-tumor target-activated polypeptide doxorubicin and preparation method and application thereof |
| 01/16/2013 | CN102875650A Preparation method of barusiban |
| 01/16/2013 | CN102875649A Method for preparing telaprevir and intermediate thereof and intermediate |
| 01/16/2013 | CN102875648A Method for preparing telaprevir |
| 01/16/2013 | CN102875647A Ligand polypeptide and medicine transferring system combined with specificity of CD40L protein |
| 01/16/2013 | CN102875646A New assays for preimplantation factor and preimplantation factor peptides |
| 01/16/2013 | CN102875645A Thymic humoral factor THF-gamma2, its derivative, their synthetic method, and their application in antitumor drugs |
| 01/16/2013 | CN102875644A GRPAK/tetrahydroglyoxaline/RGD ternary conjugate as well as preparation method and application thereof |
| 01/16/2013 | CN102875643A Major peptide fragment for synthesis of somatostatin |
| 01/16/2013 | CN102875642A Compounds for enzyme inhibition |
| 01/15/2013 | US8354499 Cyanine-based probe\tag-peptide pair fluorescence protein imaging and fluorescence protein imaging methods |
| 01/15/2013 | US8354380 NY-ESO-1 peptide analogs |
| 01/15/2013 | US8354374 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 01/15/2013 | US8354372 Cyclised alpha-conotoxin peptides |
| 01/15/2013 | CA2475929C Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/10/2013 | WO2013004399A1 Anti - amyloidogenic, alpha-helix breaking ultra-small peptide therapeutics |
| 01/10/2013 | WO2013004203A1 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases |
| 01/10/2013 | WO2012159006A8 Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof |
| 01/10/2013 | US20130012685 Novel peptides that bind to the erythropoietin receptor |
| 01/10/2013 | US20130012456 Compositions and methods for transport across the blood brain barrier |
| 01/10/2013 | US20130012451 Compositions and methods for inhibiting mmp-9-mediated cell migration |
| 01/10/2013 | US20130012432 Peptides for Treatment of Obesity |
| 01/10/2013 | US20130012430 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/10/2013 | US20130011427 Flavivirus species-specific peptide tags for vaccine and diagnostic use |
| 01/10/2013 | US20130011425 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/10/2013 | US20130011422 Tumor Antigens for the Prevention and/or Treatment of Cancer |
| 01/10/2013 | US20130011403 Klebsiella antigens |
| 01/10/2013 | US20130011362 Targeting monomers and polymers having targeting blocks |
| 01/10/2013 | US20130011335 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and SRC |
| 01/10/2013 | CA2838496A1 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases |
| 01/09/2013 | EP2542571A1 Oligomer-specific amyloid beta epitope and antibodies |
| 01/09/2013 | CN102869677A Treatments for gastrointestinal disorders |
| 01/09/2013 | CN102869676A Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability |
| 01/09/2013 | CN102869675A Cyclic peptides binding CXCR4 receptor and relative medical and diagnostic uses |
| 01/09/2013 | CN102869367A Novel cyclic peptides |
| 01/09/2013 | CN102863518A Polymyxin B compound and preparation method thereof |
| 01/09/2013 | CN102863517A Goserelin purification method |